Beximco Pharmaceuticals Limited (R2WA.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
At close: 10:59AM CEST
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 410.20M |
| Enterprise Value | 457.12M |
| Trailing P/E | 4.81 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.59 |
| Price/Book (mrq) | 0.55 |
| Enterprise Value/Revenue | 1.37 |
| Enterprise Value/EBITDA | 7.33 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.63 |
| 52-Week Change 3 | 5.71% |
| S&P500 52-Week Change 3 | 26.36% |
| 52 Week High 3 | 0.5000 |
| 52 Week Low 3 | 0.3700 |
| 50-Day Moving Average 3 | 0.4186 |
| 200-Day Moving Average 3 | 0.4340 |
Share Statistics
| Avg Vol (3 month) 3 | 672 |
| Avg Vol (10 day) 3 | 480 |
| Shares Outstanding 5 | 446.11M |
| Implied Shares Outstanding 6 | 923.88M |
| Float 8 | 297.32M |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 1.72% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.03 |
| Forward Annual Dividend Yield 4 | 6.64% |
| Trailing Annual Dividend Rate 3 | 3.50 |
| Trailing Annual Dividend Yield 3 | 788.29% |
| 5 Year Average Dividend Yield 4 | 4.06 |
| Payout Ratio 4 | 29.75% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Nov 10, 2023 |
| Last Split Factor 2 | 1.1:1 |
| Last Split Date 3 | Nov 23, 2020 |
Financial Highlights
Currency in BDT.Fiscal Year
| Fiscal Year Ends | Jun 30, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 12.37% |
| Operating Margin (ttm) | 17.20% |
Management Effectiveness
| Return on Assets (ttm) | 6.97% |
| Return on Equity (ttm) | 10.99% |
Income Statement
| Revenue (ttm) | 43.08B |
| Revenue Per Share (ttm) | 96.58 |
| Quarterly Revenue Growth (yoy) | 15.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 9.44B |
| Net Income Avi to Common (ttm) | 5.33B |
| Diluted EPS (ttm) | 0.0900 |
| Quarterly Earnings Growth (yoy) | 43.50% |
Balance Sheet
| Total Cash (mrq) | 1.73B |
| Total Cash Per Share (mrq) | 3.88 |
| Total Debt (mrq) | 7.43B |
| Total Debt/Equity (mrq) | 14.73% |
| Current Ratio (mrq) | 1.80 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 8.37B |
| Levered Free Cash Flow (ttm) | 4.42B |
© 2024 Yahoo. All rights reserved.